Notes

Axcelis Technologies, Inc. (ACLS) designs, manufactures and services ion implantation, dry strip, thermal processing and curing equipment used in the fabrication of semiconductor chips. In addition to equipment, the Company provides aftermarket service and support, including spare parts, equipment upgrades, maintenance services and customer training. Axcelis has exclusively licensed its Japanese joint venture, SEN Corporation (SEN), an SHI and Axcelis Company, to manufacture and sell specific ion implanter systems covered by its technology in Japan. The Company owns 50% of the equity of SEN. Sumitomo Heavy Industries, Ltd., a Japanese corporation, holds the other 50% of the equity of SEN. An exclusive license was granted to SEN to use the Company's patented and unpatented technology to manufacture, use and sell specified ion implant products in Japan.

16SEP07 - $5

RATINGS
Schwab: D
Goldman-Sachs: Buy
Standard & Poors: 3 stars

Market Cap (intraday): 490.19M
Enterprise Value (17-Sep-07): 486.78M
Trailing P/E (ttm, intraday): 13.79
Forward P/E (fye 31-Dec-08) : 12.00
PEG Ratio (5 yr expected): 2.04
Price/Sales (ttm): 1.08
Price/Book (mrq): 1.01

Price/Cash Flow Ratio 8.80

Total Debt/Equity (mrq): 0.161
Current Ratio (mrq): 4.052

Insiders buying since early August, at less than $5.

GROWTH
Earnings: Current Qtr. -83.3%. Next Qtr. -66.7%
Next Year 150.0%
Next 5 Years (per annum) 14.94%

---

top of page